NASDAQ : CORT

Corcept Therapeutics Incorporated — Financial statements

Healthcare · Biotechnology · United States

Last price 85.95 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.29B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Corcept Therapeutics Incorporated (CORT) reported revenue of 830.81M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue830.81M761.41M675.04M482.38M401.86M365.98M
Cost of Revenue14.09M12.98M10.88M6.48M5.38M5.28M
Gross Profit816.73M748.43M664.16M475.89M396.47M360.70M
Selling, General & Admin556.47M448.73M280.32M184.26M152.85M122.36M
Research & Development253.86M254.91M246.89M184.35M130.99M113.86M
Operating Expenses810.32M703.63M527.21M368.61M283.84M236.22M
Operating Income6.41M44.80M136.95M107.28M112.63M124.48M
Interest & Investment Income19.96M21.67M24.54M17.27M3.56M529.00K
Legal Settlements-14.00M
Pretax Income26.37M66.46M161.49M124.56M116.19M125.01M
Income Tax Expense-28.81M-33.19M20.28M18.42M14.77M12.49M
Net Income55.18M99.65M141.21M106.14M101.42M112.51M
Preferred Dividends & Other Adjustments912.00K1.48M1.48M644.00K130.00K
Net Income to Common54.27M98.17M139.73M105.50M101.29M112.51M
Shares Outstanding (Basic)104.26M103.86M103.23M103.56M106.79M115.65M
Shares Outstanding (Diluted)118.06M119.99M113.48M111.74M115.97M125.96M
EPS (Basic)0.520.951.351.020.950.97
EPS (Diluted)0.450.821.230.940.870.89
Free Cash Flow106.92M141.78M196.12M126.54M119.91M167.42M
Free Cash Flow Per Share0.911.181.731.131.031.33
Gross Margin98.30%98.30%98.39%98.66%98.66%98.56%
Operating Margin0.77%5.88%20.29%22.24%28.03%34.01%
Profit Margin6.53%12.89%20.70%21.87%25.20%30.74%
Free Cash Flow Margin12.87%18.62%29.05%26.23%29.84%45.75%
EBITDA8.08M45.95M137.75M108.32M113.89M125.96M
EBITDA Margin0.97%6.03%20.41%22.46%28.34%34.42%
D&A For EBITDA1.68M1.15M795.00K1.04M1.26M1.48M
EBIT6.41M44.80M136.95M107.28M112.63M124.48M
EBIT Margin0.77%5.88%20.29%22.24%28.03%34.01%
Effective Tax Rate12.56%14.79%12.71%9.99%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents111.04M120.50M127.67M135.55M66.33M77.62M
Short-Term Investments197.16M251.66M255.67M232.67M365.34M145.92M
Cash & Short-Term Investments308.20M372.15M383.33M368.22M431.67M223.53M
Accounts Receivable76.92M59.79M53.98M41.12M31.06M27.62M
Other Receivables14.00M15.80M1.40M
Receivables76.92M59.79M53.98M55.12M46.86M29.02M
Inventory13.19M12.87M12.41M7.73M6.10M4.99M
Prepaid Expenses17.57M23.26M9.49M4.32M14.62M8.91M
Other Current Assets23.81M17.40M12.39M23.24M
Total Current Assets439.68M485.46M471.60M458.64M499.25M266.46M
Property, Plant & Equipment11.99M6.47M8.01M315.00K1.78M1.52M
Long-Term Investments236.45M160.27M219.83M57.18M4.95M112.28M
Long-Term Deferred Tax Assets178.68M168.20M130.91M90.61M61.47M27.45M
Other Long-Term Assets21.90M16.25M10.19M14.79M15.99M16.05M
Total Assets888.70M836.65M840.55M621.52M583.43M423.76M
Accounts Payable14.91M40.44M15.38M17.40M11.98M6.91M
Accrued Expenses122.22M117.64M120.52M70.49M44.52M39.30M
Current Portion of Leases1.92M1.08M829.00K151.00K1.14M526.00K
Current Income Taxes Payable1.81M89.00K513.00K
Other Current Liabilities14.75M6.91M4.04M14.65M14.76M296.00K
Total Current Liabilities153.80M166.09M140.77M104.50M72.49M47.54M
Long-Term Leases7.50M5.02M6.11M
Other Long-Term Liabilities21.62M17.74M14.08M10.31M9.10M409.00K
Total Liabilities182.93M188.85M160.96M114.81M81.59M47.95M
Common Stock142.00K140.00K136.00K133.00K131.00K127.00K
Additional Paid-In Capital1.05B968.60M832.11M738.51M662.34M591.35M
Retained Earnings654.61M643.39M543.74M402.53M296.39M194.97M
Treasury Stock-998.01M-966.59M-696.17M-635.08M-456.15M-410.41M
Comprehensive Income & Other436.00K2.26M-217.00K609.00K-869.00K-227.00K
Shareholders' Equity705.78M647.80M679.59M506.70M501.84M375.81M
Total Liabilities & Equity888.70M836.65M840.55M621.52M583.43M423.76M
Total Debt9.42M6.11M6.94M151.00K1.14M526.00K
Net Cash (Debt)535.23M526.32M596.23M425.25M435.48M335.29M
Net Cash Per Share4.534.395.253.813.762.66
Filing Date Shares Outstanding108.10M106.37M105.50M103.52M107.90M105.96M
Total Common Shares Outstanding107.92M105.97M105.11M103.41M107.83M105.94M
Working Capital285.87M319.38M330.83M354.13M426.76M218.92M
Book Value Per Share6.546.116.474.904.653.55
Tangible Book Value705.78M647.80M679.59M506.70M501.84M375.81M
Tangible Book Value Per Share6.546.116.474.904.653.55
Machinery1.16M
Leasehold Improvements1.26M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income55.18M99.65M141.21M106.14M101.42M112.51M
Depreciation & Amortization2.42M1.89M1.34M2.36M3.45M3.48M
Loss (Gain) From Sale of Investments-3.64M-5.10M-10.94M-9.13M1.38M
Stock-Based Compensation96.11M84.50M61.35M48.94M42.44M42.93M
Other Operating Activities-16.30M-37.54M-40.19M-29.49M-33.91M9.44M
Change in Accounts Receivable-12.35M-5.81M-12.85M-10.07M-3.43M-1.43M
Change in Inventory-11.00M-7.48M305.00K1.26M1.20M3.44M
Change in Accounts Payable-8.97M25.07M-2.02M5.42M4.76M-3.60M
Change in Income Taxes1.09M1.09M3.78M1.21M8.69M11.00K
Change in Other Net Operating Assets7.15M-14.28M56.32M10.03M-5.67M1.10M
Operating Cash Flow109.70M142.00M198.29M126.68M120.32M167.89M
Capital Expenditures-2.78M-211.00K-2.17M-139.00K-413.00K-469.00K
Investment in Securities-19.12M69.97M-175.43M91.05M-113.91M136.59M
Investing Cash Flow-21.90M69.76M-177.60M90.91M-114.33M136.13M
Issuance of Common Stock25.47M25.49M9.62M5.81M4.38M16.23M
Repurchase of Common Stock-104.37M-245.86M-37.97M-154.53M-21.66M-318.82M
Financing Cash Flow-78.91M-220.37M-28.35M-148.72M-17.28M-302.59M
Foreign Exchange Rate Adjustments-602.00K1.44M-228.00K358.00K
Net Cash Flow8.29M-7.17M-7.89M69.22M-11.29M1.43M
Free Cash Flow106.92M141.78M196.12M126.54M119.91M167.42M
Free Cash Flow Margin12.87%18.62%29.05%26.23%29.84%45.75%
Free Cash Flow Per Share0.911.181.731.131.031.33
Levered Free Cash Flow77.40M114.19M183.85M128.39M115.55M120.18M
Unlevered Free Cash Flow77.40M114.19M183.85M128.39M115.55M120.18M
Cash Income Tax Paid12.97M12.97M60.27M47.60M39.75M9.10M
Change in Working Capital-24.07M-1.41M45.52M7.86M5.54M-466.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization8.77B3.66B5.28B3.35B2.19B2.10B
Enterprise Value8.23B3.14B4.74B2.93B1.79B1.60B
Last Close Price81.1234.8050.3932.4820.3119.80
PE Ratio178.8237.2937.7831.7421.5918.64
Forward PE21.1455.5332.1132.6119.9521.01
PS Ratio10.554.817.826.945.445.73
PB Ratio12.405.657.776.614.365.58
P/TBV Ratio12.425.657.776.614.365.58
P/FCF Ratio82.0125.8226.9226.4618.2312.53
P/OCF Ratio79.9425.7826.6226.4318.1712.49
PEG Ratio1.961.961.961.961.50
EV/Sales Ratio9.914.137.026.084.454.38
EV/EBITDA Ratio1,018.5268.4034.4027.0815.6912.73
EV/EBIT Ratio1,285.5170.1534.6027.3415.8712.88
EV/FCF Ratio77.0122.1624.1623.1814.909.58
Debt / Equity Ratio0.010.010.010.000.000.00
Debt / EBITDA Ratio0.860.130.050.000.010.00
Debt / FCF Ratio0.090.040.040.000.010.00
Net Debt / Equity Ratio-0.76-0.81-0.88-0.84-0.87-0.89
Net Debt / EBITDA Ratio-66.21-11.46-4.33-3.93-3.82-2.66
Net Debt / FCF Ratio-5.01-3.71-3.04-3.36-3.63-2.00
Asset Turnover0.980.910.920.800.800.73
Inventory Turnover1.111.031.080.940.971.07
Quick Ratio2.502.603.114.056.605.31
Current Ratio2.862.923.354.396.895.61
Return on Equity (ROE)8.23%15.02%23.81%21.05%23.11%25.03%
Return on Assets (ROA)0.47%3.34%11.71%11.13%13.98%15.63%
Return on Invested Capital (ROIC)1.79%15.32%54.21%87.09%87.74%94.15%
Return on Capital Employed (ROCE)0.90%6.70%19.60%20.80%22.00%33.10%
Earnings Yield0.56%2.72%2.67%3.17%4.64%5.36%
FCF Yield1.22%3.87%3.72%3.78%5.48%7.98%
Buyback Yield / Dilution0.22%-5.73%-1.55%3.64%7.94%-1.42%